Nesiritide vs Vasopressin
Research Verdict
Vasopressin is the stronger research reference for the stated comparison criteria. Vasopressin (ADH): established role as second-line vasopressor in septic shock (VASST trial, Russell 2008, n=778) and cardiac arrest (AHA guidelines).
Quick Answers
Which is better, Nesiritide or Vasopressin?
Vasopressin is the stronger research reference for the stated comparison criteria. Vasopressin (ADH): established role as second-line vasopressor in septic shock (VASST trial, Russell 2008, n=778) and cardiac arrest (AHA guidelines).
What is the key difference between Nesiritide and Vasopressin?
Vasopressin is a vasopressor used in hemodynamic emergencies; nesiritide was a vasodilator for heart failure symptom relief - opposite hemodynamic effects for different clinical scenarios.
Evidence Comparison
Vasopressin (ADH): established role as second-line vasopressor in septic shock (VASST trial, Russell 2008, n=778) and cardiac arrest (AHA guidelines). Nesiritide: ASCEND-HF showed no benefit in acute heart failure. Vasopressin has validated guideline-level evidence; nesiritide does not.
Evidence Context Favoring Nesiritide
No current scenario favors nesiritide over vasopressin - they target different conditions, and nesiritide failed in its indication.
Evidence Context Favoring Vasopressin
Septic shock or vasodilatory shock requiring pressor support; vasopressin has guideline-supported evidence as a second-line agent.
Side-by-Side Snapshot
| Evidence grade | Nesiritide: Level A Vasopressin: Level A |
|---|---|
| Research status | Nesiritide: FDA Approved Vasopressin: FDA Approved |
| Primary category | Nesiritide: Healing & Recovery Vasopressin: Healing & Recovery |
| Cited studies | Nesiritide: 3 Vasopressin: 3 |